
  
    
      
        Background_NNP
        In_IN 1960_CD Nowell_NNP first_RB described_VBD lymphocyte_NN activation_NN by_IN
        mitogenic_JJ lectins_NNS to_TO result_VB in_IN "_'' blastic_JJ transformation_NN "_'' and_CC
        subsequent_JJ mitosis_NNS ,_, which_WDT are_VBP complex_JJ cellular_JJ events_NNS that_WDT
        require_VBP several_JJ days_NNS to_TO evolve_VB [_NN 1_CD ]_NN ._. More_JJR than_IN 40_CD years_NNS
        later_RB ,_, we_PRP have_VBP advanced_VBN considerably_RB in_IN our_PRP$ understanding_NN
        of_IN the_DT cellular_JJ and_CC molecular_JJ events_NNS responsible_JJ for_IN these_DT
        phenomena_NNS ._. Now_RB with_IN the_DT genomic_JJ revolution_NN ,_, we_PRP are_VBP poised_VBN
        on_IN a_DT new_JJ threshold_NN of_IN discovery_NN ,_, in_IN that_IN it_PRP is_VBZ finally_RB
        feasible_JJ to_TO begin_VB to_TO identify_VB the_DT genes_NNS that_WDT are_VBP
        responsible_JJ for_IN such_JJ complicated_VBN cellular_JJ processes_NNS ._.
        However_RB ,_, it_PRP is_VBZ now_RB necessary_JJ to_TO develop_VB an_DT experimental_JJ
        approach_NN that_WDT will_MD rapidly_RB and_CC accurately_RB facilitate_VB the_DT
        discovery_NN process_NN ._.
        With_IN the_DT description_NN of_IN lymphocyte-derived_JJ growth_NN factor_NN
        activities_NNS in_IN the_DT 1960_CD s_VBZ and_CC 1970_CD s_VBZ ,_, it_PRP was_VBD realized_VBN that_WDT
        activated_VBN lymphocytes_NNS secrete_NN soluble_JJ factors_NNS that_WDT are_VBP
        critical_JJ for_IN subsequent_JJ lymphocyte_NN proliferation_NN [_NN 2_CD 3_CD ]_NN ._.
        Moreover_RB ,_, in_IN 1967_CD it_PRP was_VBD demonstrated_VBN that_IN monocytes_NNS or_CC
        macrophages_NNS serve_VBP as_IN necessary_JJ accessory_JJ cells_NNS for_IN the_DT
        lymphocyte_NN activation_NN process_NN [_NN 4_CD ]_NN ._. Then_RB ,_, in_IN the_DT early_JJ
        1970_CD s_VBZ several_JJ reports_NNS indicated_VBD that_DT mitogen-_NN or_CC
        endotoxin-stimulated_JJ macrophages_NNS release_VBP soluble_JJ lymphocyte_NN
        activating_VBG factors_NNS (_( LAFs_NNP )_) that_IN also_RB amplify_VB the_DT activation_NN
        process_NN [_NN 5_CD 6_CD ]_NN ._. Accordingly_RB ,_, lymphokines_NNS and_CC monokines_NNS ,_,
        which_WDT collectively_RB came_VBD to_TO be_VB known_VBN as_IN cytokines_NNS ,_, became_VBD
        prime_JJ research_NN subjects_NNS for_IN those_DT interested_JJ in_IN lymphocyte_NN
        activation_NN [_NN 7_CD 8_CD ]_NN ._. However_RB ,_, it_PRP was_VBD not_RB until_IN the_DT 1980_CD s_VBZ
        that_IN the_DT cell_NN surface_NN and_CC soluble_JJ molecules_NNS responsible_JJ for_IN
        the_DT complex_JJ cellular_JJ changes_NNS of_IN lymphocyte_NN activation_NN were_VBD
        identified_VBN ._.
        With_IN the_DT isolation_NN of_IN the_DT lymphocyte-derived_JJ molecule_NN
        responsible_JJ for_IN T_NN cell_NN Growth_NN Factor_NN (_( TCGF_NNP )_) activity_NN ,_, which_WDT
        came_VBD to_TO be_VB known_VBN as_IN interleukin_NN 2_CD (_( IL-_NNP 2_LS )_) [_NN 9_CD 10_CD ]_NN ,_, and_CC
        discovery_NN of_IN IL-_NNP 2_CD receptors_NNS (_( IL-_NNP 2_CD R_NN )_) [_NN 11_CD ]_NN ,_, it_PRP could_MD be_VB
        shown_VBN that_IN mitogenic_JJ lectins_NNS and_CC specific_JJ antigens_NNS
        triggered_VBD an_DT initial_JJ activation_NN event_NN ,_, which_WDT was_VBD analogous_JJ
        to_TO the_DT activation_NN of_IN cell_NN cycle_NN "_'' competence_NN "_'' by_IN
        serum-stimulated_JJ fibroblasts_NNS ,_, and_CC resulted_VBD in_IN transition_NN
        from_IN the_DT G_NNP 
        0_CD to_TO the_DT G_NNP 
        1_CD phase_NN of_IN the_DT cell_NN cycle_NN [_NN 12_CD 13_CD ]_NN ._.
        However_RB ,_, just_RB as_IN in_IN serum-stimulated_JJ fibroblasts_NNS ,_, this_DT
        initial_JJ activation_NN event_NN did_VBD not_RB result_VB in_IN lymphocyte_NN
        proliferation_NN ._. Instead_RB ,_, it_PRP appeared_VBD that_IN the_DT initial_JJ
        activation_NN of_IN cellular_JJ competence_NN triggered_VBN by_IN the_DT
        mitogenic_JJ lectins_NNS was_VBD amplified_VBN by_IN the_DT LAF_NNP activity_NN ,_, which_WDT
        became_VBD known_VBN later_RB as_IN IL-_NNP 1_CD ,_, and_CC led_VBD to_TO the_DT secretion_NN of_IN the_DT
        lymphocyte-derived_JJ IL-_NNP 2_CD and_CC the_DT expression_NN of_IN IL-_NNP 2_CD Rs_NNP [_NN 14_CD
        15_CD ]_NN ._. The_DT subsequent_JJ interaction_NN of_IN IL-_NNP 2_CD with_IN the_DT IL-_NNP 2_CD Rs_NNP
        then_RB stimulated_VBN blastic_JJ transformation_NN and_CC progression_NN
        through_IN G_NNP 
        1_CD and_CC into_IN the_DT S_NNP phase_NN of_IN the_DT cell_NN
        cycle_NN ,_, followed_VBN by_IN mitosis_NNS [_NN 16_CD ]_NN ._. Furthermore_RB ,_, detailed_JJ
        studies_NNS indicated_VBD that_IN successful_JJ activation_NN of_IN the_DT IL-_NNP 2_CD R_NN
        is_VBZ a_DT quantal_NN (_( i_NNP ._. e_SYM ._. all-or-none_JJ )_) event_NN that_WDT depends_VBZ on_IN
        surpassing_VBG a_DT threshold_NN of_IN a_DT finite_JJ number_NN of_IN IL-_NNP 2_CD -_: IL-_NNP 2_CD R_NN
        interactions_NNS [_NN 13_CD 17_CD 18_CD ]_NN ._. This_DT threshold_NN corresponds_NNS to_TO
        surpassing_VBG the_DT "_'' restriction_NN (_( R_NN )_) point_NN "_'' in_IN the_DT mid_JJ to_TO late_JJ G_NNP
        
        1_LS phase_NN of_IN the_DT cell_NN cycle_NN ,_, first_RB
        described_VBN by_IN Pardee_NNP for_IN serum-activated_JJ fibroblasts_NNS [_NN 19_CD ]_NN
        ._. Accordingly_RB ,_, activation_NN of_IN lymphocyte_NN proliferation_NN was_VBD
        realized_VBN to_TO require_VB at_IN least_JJS 3_CD signals_NNS ,_, one_CD delivered_VBN to_TO
        the_DT T_NN cell_NN via_IN the_DT lectin_NN ,_, another_DT supplied_VBN as_IN a_DT soluble_JJ
        factor_NN by_IN accessory_JJ macrophages_NNS ,_, and_CC a_DT third_JJ contributed_VBN by_IN
        the_DT IL-_NNP 2_CD /_NN IL-_NNP 2_CD R_NN interaction_NN ._.
        With_IN the_DT discovery_NN of_IN the_DT T_NN cell_NN antigen_NN receptor_NN (_( TCR_NNP )_)
        in_IN 1983_CD [_NN 20_CD 21_CD 22_CD ]_NN it_PRP was_VBD possible_JJ to_TO demonstrate_VB that_IN
        the_DT first_JJ signal_NN is_VBZ delivered_VBN via_IN antigenic_JJ activation_NN of_IN
        the_DT TCR_NNP [_NN 12_CD ]_NN ._. Subsequently_NNP ,_, discovery_NN of_IN accessory_JJ
        "_'' co-stimulatory_JJ "_'' molecule_NN expression_NN by_IN "_'' helper_NN "_'' T_NN cells_NNS
        (_( Th_NNP )_) ,_, revealed_VBD that_DT activation_NN solely_RB of_IN the_DT TCR_NNP itself_PRP was_VBD
        insufficient_JJ to_TO fully_RB activate_VBP IL-_NNP 2_CD gene_NN expression_NN and_CC T_NN
        cell_NN proliferation_NN ._. Instead_RB ,_, in_IN the_DT mid_JJ '_POS 80_CD s_VBZ it_PRP was_VBD found_VBN
        that_IN the_DT activation_NN of_IN co-stimulatory_JJ molecules_NNS like_IN CD_NNP 28_CD
        expressed_VBN by_IN T_NN cells_NNS via_IN ligands_NNS such_JJ as_IN B_NNP 7_CD expressed_VBN by_IN
        antigen_NN presenting_VBG cells_NNS (_( APC_NNP )_) ,_, deliver_VB additional_JJ signals_NNS
        that_WDT synergize_NN with_IN those_DT emanating_VBG from_IN the_DT TCR_NNP ,_, and_CC
        result_NN in_IN maximal_NN IL-_NNP 2_CD gene_NN transcription_NN [_NN 23_CD ]_NN ._. As_IN well_RB ,_,
        CD_NNP 28_CD activation_NN stabilizes_VBZ IL-_NNP 2_CD mRNA_NN transcripts_NNS ,_,
        prolonging_VBG IL-_NNP 2_CD mRNA_NN life_NN span_NN [_NN 24_CD ]_NN ._. Thus_RB ,_, in_IN addition_NN
        to_TO soluble_JJ macrophage-derived_JJ products_NNS ,_, cell_NN surface_NN
        molecules_NNS expressed_VBN by_IN APCs_NNP also_RB contribute_VBP to_TO the_DT 2_CD
        ndsignal_NN attributed_VBD to_TO the_DT APCs_NNP ._.
        The_DT molecules_NNS responsible_JJ for_IN the_DT contribution_NN by_IN the_DT
        soluble_JJ macrophage-derived_JJ LAFs_NNP still_RB remain_VBP obscure_JJ ,_, even_RB
        today_NN ._. Initially_RB the_DT nomenclature_NN of_IN IL-_NNP 1_CD and_CC IL-_NNP 2_CD was_VBD
        created_VBN to_TO delineate_NN the_DT sequential_NN action_NN of_IN an_DT assumed_VBN
        single_JJ macrophage-derived_JJ soluble_JJ factor_NN (_( IL-_NNP 1_LS )_) ,_, which_WDT
        promoted_VBD the_DT production_NN of_IN a_DT single_JJ lymphocyte-derived_JJ
        factor_NN (_( IL-_NNP 2_LS )_) [_NN 14_CD 15_CD 25_CD ]_NN ._. However_RB ,_, the_DT molecular_JJ nature_NN
        of_IN the_DT LAF_NNP activity_NN was_VBD never_RB fully_RB elucidated_JJ ,_, even_RB after_IN
        the_DT isolation_NN and_CC identification_NN of_IN multiple_JJ
        mitogen_NN /_NN endotoxin-stimulated_JJ macrophage-derived_JJ products_NNS ,_,
        such_JJ as_IN IL-_NNP 1_CD ,_, IL-_NNP 6_CD ,_, IL-_NNP 12_CD ,_, IL-_NNP 18_CD ,_, and_CC Tumor_NNP Necrosis_NNP
        Factor-alpha_NNP (_( TNF-α_NNP )_) ._. It_PRP is_VBZ probable_JJ that_IN 
        all_DT of_IN these_DT macrophage-derived_JJ
        soluble_JJ factors_NNS together_RB make_VBP up_RP the_DT activity_NN originally_RB
        ascribed_VBN to_TO LAF_NNP ._. Accordingly_RB ,_, it_PRP is_VBZ obvious_JJ that_DT addition_NN
        of_IN a_DT polyclonal_NN activating_VBG ligand_NN such_JJ as_IN
        phytohemagglutinin_NN to_TO peripheral_JJ blood_NN mononuclear_NN cells_NNS
        (_( PBMCs_NNP )_) leads_VBZ to_TO the_DT activation_NN of_IN soluble_JJ
        macrophage-derived_JJ and_CC lymphocyte-derived_JJ activating_VBG
        factors_NNS ,_, and_CC the_DT almost_RB simultaneous_JJ activation_NN of_IN multiple_JJ
        cell_NN surface_NN receptors_NNS ,_, signaling_VBG pathways_NNS and_CC
        transcription_NN factors_NNS that_IN ultimately_RB all_DT contribute_VBP to_TO
        lymphocyte_NN activation_NN ._.
        Stimulation_NNP of_IN the_DT various_JJ receptors_NNS expressed_VBN by_IN T_NN
        cells_NNS and_CC APCs_NNP results_NNS in_IN the_DT activation_NN of_IN distinct_JJ and_CC
        also_RB redundant_JJ signal_NN transduction_NN pathways_NNS ,_, and_CC in_IN the_DT
        activation_NN of_IN distinct_JJ as_IN well_RB as_IN redundant_JJ transcription_NN
        factors_NNS ._. Accordingly_RB ,_, it_PRP has_VBZ been_VBN assumed_VBN that_IN triggering_VBG
        any_DT of_IN these_DT receptors_NNS should_MD result_VB in_IN the_DT expression_NN of_IN
        distinct_JJ as_IN well_RB as_IN redundant_JJ cellular_JJ genes_NNS ._. Until_IN
        recently_RB the_DT identification_NN of_IN large_JJ numbers_NNS of_IN genes_NNS
        triggered_VBN by_IN distinct_JJ ligands_NNS has_VBZ been_VBN difficult_JJ ,_, owing_VBG to_TO
        the_DT cumbersome_JJ methods_NNS available_JJ for_IN gene_NN identification_NN ._.
        Cochran_NNP and_CC Stiles_NNP were_VBD among_IN the_DT first_JJ to_TO use_VB differential_NN
        cloning_VBG methods_NNS to_TO identify_VB PDGF-regulated_NNP genes_NNS in_IN
        fibroblasts_NNS [_NN 26_CD ]_NN ._. These_DT investigators_NNS focused_VBN on_IN the_DT
        expression_NN of_IN immediate_JJ /_NN early_JJ PDGF-stimulated_NNP genes_NNS ,_, by_IN
        activating_VBG the_DT cells_NNS in_IN the_DT presence_NN of_IN inhibitors_NNS of_IN
        protein_NN synthesis_NN such_JJ as_IN cycloheximide_NN ,_, thereby_RB preventing_VBG
        the_DT expression_NN of_IN secondary_JJ genes_NNS ._.
        Subsequently_RB ,_, Zipfel_NNP and_CC co-workers_NNS employed_VBN subtractive_JJ
        hybridization_NN to_TO isolate_VB and_CC differentially_RB clone_NN
        immediate_JJ /_NN early_JJ genes_NNS activated_VBN via_IN the_DT T_NN cell_NN antigen_NN
        receptor_NN in_IN the_DT presence_NN of_IN cycloheximide_NN [_NN 27_CD ]_NN ._. A_DT total_NN
        of_IN 60_CD novel_NN TCR-induced_NNP immediate_JJ /_NN early_JJ genes_NNS were_VBD
        isolated_VBN ,_, but_CC most_JJS were_VBD not_RB identified_VBN at_IN the_DT time_NN ,_, in_IN that_DT
        DNA_NNP cloning_VBG and_CC sequencing_VBG methods_NNS were_VBD tedious_JJ and_CC time_NN
        consuming_NN ._.
        New_JJ differential_NN cloning_VBG methods_NNS were_VBD developed_VBN
        subsequently_RB ,_, including_VBG differential_NN display_NN [_NN 28_CD ]_NN ,_,
        sulfhydryl_NN labeling_VBG and_CC affinity_NN purification_NN of_IN
        newly-synthesized_JJ transcripts_NNS [_NN 29_CD ]_NN ,_, representational_NN
        difference_NN analysis_NN [_NN 30_CD ]_NN ,_, and_CC serial_NN analysis_NN of_IN gene_NN
        expression_NN [_NN 31_CD ]_NN ._. Each_DT methodological_JJ advance_NN has_VBZ
        improved_VBN both_DT the_DT sensitivity_NN of_IN detection_NN of_IN
        differentially_RB expressed_VBD genes_NNS ,_, as_RB well_RB as_IN the_DT speed_NN with_IN
        which_WDT the_DT genes_NNS may_MD be_VB identified_VBN ._. However_RB ,_, the_DT development_NN
        of_IN DNA_NNP microarray_NN technology_NN ,_, which_WDT allows_VBZ rapid_JJ
        interrogation_NN of_IN thousands_NNS of_IN genes_NNS and_CC the_DT detection_NN of_IN
        gene_NN expression_NN at_IN frequencies_NNS even_RB less_JJR than_IN 1_CD in_IN 100_CD ,_, 000_CD ,_,
        has_VBZ now_RB greatly_RB facilitated_JJ such_JJ experimentation_NN [_NN 32_CD 33_CD ]_NN
        ._. This_DT communication_NN represents_VBZ our_PRP$ initial_JJ efforts_NNS to_TO use_VB
        DNA_NNP microarrays_NNS in_IN a_DT reductionist_NN approach_NN to_TO begin_VB to_TO
        identify_VB the_DT genes_NNS expressed_VBD as_IN a_DT consequence_NN of_IN triggering_VBG
        each_DT individual_JJ ligand_NN during_IN lymphocyte_NN activation_NN ._.
        Because_IN the_DT IL-_NNP 2_CD /_NN IL-_NNP 2_CD R_NN interaction_NN is_VBZ discrete_JJ molecularly_RB ,_,
        and_CC leads_VBZ to_TO a_DT very_RB finite_JJ ,_, quantal_NN decision_NN to_TO undergo_VB
        blastic_JJ transformation_NN ,_, DNA_NNP synthesis_NN and_CC mitosis_NNS ,_, we_PRP have_VBP
        focused_VBN our_PRP$ first_JJ efforts_NNS on_IN identifying_VBG IL-_NNP 2_CD -_: regulated_VBN
        genes_NNS expressed_VBN by_IN normal_JJ human_JJ T_NN cells_NNS ._.
      
      
        Results_NNS
        
          Detection_NNP of_IN IL-_NNP 2_CD -_: regulated_VBN genes_NNS in_IN peripheral_JJ
          blood_NN mononuclear_NN cells_NNS (_( PBMCs_NNP )_)
          Responses_NNS of_IN PBMCs_NNP to_TO IL-_NNP 2_CD are_VBP complex_JJ ,_, involving_VBG
          direct_JJ effects_NNS of_IN IL-_NNP 2_CD on_IN gene_NN expression_NN by_IN T_NN cells_NNS ,_, B_NNP
          cells_NNS and_CC NK_NNP cells_NNS ,_, as_RB well_RB as_IN secondary_JJ effects_NNS mediated_JJ
          by_IN additional_JJ cytokines_NNS and_CC transcription_NN factors_NNS
          expressed_VBN by_IN these_DT cells_NNS in_IN response_NN to_TO IL-_NNP 2_CD ._. To_TO identify_VB
          the_DT maximal_NN number_NN of_IN IL-_NNP 2_CD -_: regulated_VBN genes_NNS ,_, PBMCs_NNP
          comprised_VBN of_IN ~_NN 80_CD %_NN CD_NNP 3_CD +_NN lymphocytes_NNS ,_, with_IN smaller_JJR
          fractions_NNS of_IN monocytes_NNS ,_, B_NNP cells_NNS and_CC NK_NNP cells_NNS (_( Table_NNP 1_LS )_)
          were_VBD examined_VBN ._. The_DT cells_NNS were_VBD pre-activated_JJ for_IN 72_CD hr_NN
          with_IN anti-_NN CD_NNP 3_CD to_TO induce_VB T_NN cell_NN IL-_NNP 2_CD receptor_NN expression_NN ,_,
          then_RB washed_VBN and_CC rested_VBD for_IN 36_CD -_: 40_CD hr_NN ,_, prior_RB to_TO
          restimulation_NN with_IN IL-_NNP 2_CD for_IN 4_CD hr_NN [_NN 16_CD ]_NN ._.
          Five_CD independent_JJ experiments_NNS were_VBD performed_VBN with_IN PBMCs_NNP
          from_IN different_JJ donors_NNS to_TO identify_VB IL-_NNP 2_CD -_: regulated_VBN genes_NNS
          represented_VBD on_IN the_DT Affymetrix_NNP U_NNP 95_CD Av_NNP 2_CD oligonucleotide_NN
          array_NN ._. A_DT comparison_NN was_VBD made_VBN between_IN the_DT pre-activated_JJ ,_,
          rested_VBD cells_NNS ,_, and_CC those_DT restimulated_JJ with_IN IL-_NNP 2_CD for_IN 4_CD hr_NN ._.
          The_DT expression_NN levels_NNS were_VBD analyzed_VBN using_VBG DNA-Chip_NNP
          Analyzer_NNP software_NN [_NN 34_CD ]_NN ,_, with_IN normalization_NN to_TO the_DT
          average_JJ chip_NN signal_NN intensity_NN for_IN each_DT experiment_NN ,_, and_CC a_DT
          10_CD thpercentile_NN value_NN cut-off_JJ for_IN '_POS absent_JJ '_POS genes_NNS ._.
          Approximately_RB 45_CD %_NN of_IN the_DT ~_NN 12_CD ,_, 600_CD probe_NN sets_NNS were_VBD detected_VBN
          above_IN background_NN ._. Using_VBG the_DT criterion_NN of_IN p_NN <_NN 0_CD ._. 05_CD for_IN
          the_DT difference_NN of_IN means_NNS between_IN the_DT two_CD groups_NNS ,_, a_DT total_NN
          of_IN 316_CD of_IN these_DT ~_NN 5_CD ,_, 800_CD probe_NN sets_NNS (_( ~_NN 5_CD ._. 4_LS %_NN )_) were_VBD identified_VBN
          as_IN putative_JJ IL-_NNP 2_CD -_: responsive_JJ genes_NNS ._. A_DT complete_JJ list_NN of_IN all_DT
          IL-_NNP 2_CD -_: responsive_JJ genes_NNS identified_VBN in_IN PBMCs_NNP and_CC T_NN cells_NNS can_MD
          be_VB found_VBN in_IN the_DT attached_VBN file_NN '_POS IL-_NNP 2_CD -_: regulated_VBN genes_NNS '_'' ._.
          Additional_JJ File_NNP 1_CD
          IL-_NNP 2_CD target_NN genes_NNS in_IN human_JJ PBMCs_NNP and_CC T_NN cells_NNS This_DT file_NN
          contains_VBZ expression_NN data_NNS for_IN IL-_NNP 2_CD -_: regulated_VBN probe_NN sets_NNS
          detected_VBD on_IN the_DT Affymetrix_NNP U_NNP 95_CD Av_NNP 2_CD array_NN ,_, using_VBG samples_NNS
          prepared_VBN from_IN human_JJ PBMCs_NNP and_CC purified_JJ T_NN cells_NNS ._. These_DT are_VBP
          the_DT probe_NN sets_NNS depicted_VBN in_IN Figure_NN 2_CD A_DT ._.
          Click_NNP here_RB for_IN file_NN
        
        
          Detection_NNP of_IN PBMC_NNP genes_NNS already_RB known_VBN to_TO be_VB
          IL-_NNP 2_CD -_: regulated_VBN
          The_DT expression_NN patterns_NNS of_IN 19_CD genes_NNS already_RB known_VBN to_TO
          be_VB IL-_NNP 2_CD -_: regulated_VBN ,_, which_WDT were_VBD represented_VBN by_IN 25_CD distinct_JJ
          probe_NN sets_NNS on_IN the_DT array_NN ,_, were_VBD used_VBN to_TO determine_VB the_DT range_NN
          of_IN expression_NN parameters_NNS that_WDT might_MD be_VB most_RBS likely_JJ to_TO
          identify_VB bona_JJ fide_JJ IL-_NNP 2_CD -_: regulated_VBN genes_NNS (_( Table_NNP 2_LS )_) ._. As_IN
          negative_JJ controls_NNS ,_, glyceraldehyde-_NN 6_CD -_: phosphate_NN
          dehydrogenase_NN (_( GAPDH_NNP )_) and_CC actin_NN were_VBD used_VBN as_IN examples_NNS of_IN
          genes_NNS that_WDT do_VBP not_RB change_VB expression_NN levels_NNS under_IN the_DT
          experimental_JJ conditions_NNS used_VBN ;_: their_PRP$ expression_NN levels_NNS
          were_VBD indeed_RB constant_JJ without_IN or_CC with_IN IL-_NNP 2_CD treatment_NN (_( 1_CD ._. 04_CD
          ±_NN 0_CD ._. 06_CD and_CC 1_CD ._. 06_CD ±_NN 0_CD ._. 01_CD fold_VB change_NN ,_, respectively_RB )_) ._. By_IN
          comparison_NN ,_, the_DT 19_CD selected_VBN genes_NNS showed_VBD IL-_NNP 2_CD -_: induced_VBN
          changes_NNS in_IN expression_NN levels_NNS ,_, ranging_VBG from_IN 2_CD ._. 0_CD ±_NN 0_CD ._. 3_CD -_: fold_VB
          (_( IL-_NNP 4_CD R_NN ,_, probe_NN set_VBD 404_CD __NN at_IN )_) to_TO >_NN 80_CD -_: fold_VB (_( TNFβ_NNP 36296_CD __NN at_IN )_) ._.
          The_DT subtractive_JJ differences_NNS in_IN fluorescent_NN intensity_NN
          ranged_VBD from_IN 114_CD ±_NN 20_CD (_( c-myb_JJ 1474_CD __NN s_VBZ __NN at_IN )_) to_TO >_NN 1000_CD (_( CR_NNP 7_CD
          1779_CD __NN s_VBZ __NN at_IN )_) ._. Four_CD of_IN the_DT genes_NNS (_( c-myb_JJ ,_, CR_NNP 7_CD ,_, flt_NN 3_CD ligand_NN ,_,
          TNF-β_NNP )_) were_VBD detected_VBN with_IN more_JJR than_IN one_CD probe_NN set_VBD ,_, and_CC
          these_DT replicates_NNS were_VBD in_IN fairly_RB good_JJ agreement_NN ._. It_PRP is_VBZ
          worthy_JJ of_IN note_NN that_IN there_EX is_VBZ not_RB a_DT correlation_NN between_IN
          the_DT subtracted_VBN difference_NN and_CC the_DT fold_VB change_NN in_IN gene_NN
          expression_NN levels_NNS ._. This_DT is_VBZ likely_JJ due_NN to_TO the_DT fact_NN that_IN
          there_EX is_VBZ a_DT wide_JJ range_NN in_IN the_DT abundance_NN classes_NNS of_IN RNA_NNP
          transcripts_NNS derived_VBN from_IN different_JJ genes_NNS ,_, from_IN as_RB few_JJ as_IN
          1_CD copy_NN per_IN cell_NN to_TO several_JJ thousand_CD copies_NNS per_IN cell_NN [_NN 35_CD
          ]_NN ._. The_DT signal_NN intensity_NN of_IN a_DT particular_JJ transcript_NN
          detected_VBD on_IN an_DT oligonucleotide_NN array_NN would_MD thus_RB be_VB
          directly_RB related_VBN to_TO this_DT abundance_NN level_NN ._. Therefore_RB ,_, the_DT
          subtracted_VBN change_NN in_IN signal_NN intensity_NN would_MD be_VB profoundly_RB
          affected_VBN by_IN the_DT absolute_JJ number_NN of_IN cellular_JJ copies_NNS of_IN a_DT
          given_VBN transcript_NN ._. By_IN comparison_NN ,_, the_DT fold_VB induction_NN is_VBZ
          independent_JJ of_IN absolute_JJ transcript_NN copy_NN number_NN ._.
        
        
          Detection_NNP of_IN additional_JJ IL-_NNP 2_CD -_: responsive_JJ PBMC_NNP
          genes_NNS
          Based_VBN on_IN the_DT results_NNS obtained_VBN with_IN known_VBN IL-_NNP 2_CD target_NN
          genes_NNS ,_, the_DT criteria_NNS used_VBN to_TO identify_VB additional_JJ bona_JJ fide_JJ
          IL-_NNP 2_CD -_: regulated_VBN genes_NNS in_IN these_DT samples_NNS were_VBD set_VBN at_IN ≥_NN
          2_CD -_: fold_VB change_NN ,_, with_IN a_DT subtracted_VBN difference_NN in_IN
          fluorescent_NN intensity_NN ≥_NN 100_CD ,_, and_CC a_DT significance_NN level_NN of_IN
          the_DT difference_NN between_IN the_DT means_NNS of_IN the_DT two_CD treatment_NN
          groups_NNS of_IN p_NN <_NN 0_CD ._. 05_CD ._. Of_IN the_DT 316_CD probe_NN sets_NNS that_WDT met_VBD the_DT
          standard_NN of_IN p_NN <_NN 0_CD ._. 05_CD ,_, 251_CD (_( 79_CD %_NN )_) also_RB met_VBD the_DT
          additional_JJ criteria_NNS of_IN either_DT fold_VB change_NN ≥_NN 2_CD ,_, or_CC
          subtracted_VBD difference_NN ≥_NN 100_CD ,_, while_IN only_RB 84_CD probe_NN sets_NNS
          (_( 27_CD %_NN )_) met_VBD all_DT three_CD criteria_NNS ._.
          These_DT 84_CD probe_NN sets_NNS represent_VBP 72_CD unique_JJ genes_NNS (_( 60_CD
          IL-_NNP 2_CD -_: induced_VBN genes_NNS and_CC 12_CD IL-_NNP 2_CD -_: repressed_JJ genes_NNS )_) that_WDT can_MD
          be_VB segregated_VBD into_IN 8_CD functional_JJ groups_NNS ._. Figure_NN 1_CD shows_VBZ the_DT
          fold_VB induction_NN and_CC subtracted_VBN differences_NNS in_IN expression_NN
          levels_NNS of_IN these_DT probe_NN sets_NNS ._. Among_IN the_DT 4_CD
          apoptosis-regulating_JJ genes_NNS ,_, bcl_NN 2_CD ,_, caspase_NN 3_CD and_CC DRAK_NNP 2_CD are_VBP
          all_DT induced_VBN by_IN IL-_NNP 2_CD ,_, while_IN the_DT expression_NN of_IN Toso_NNP is_VBZ
          suppressed_VBN ._. It_PRP is_VBZ noteworthy_JJ that_IN the_DT IL-_NNP 2_CD induction_NN of_IN
          bcl_NN 2_CD would_MD be_VB expected_VBN to_TO promote_VB cellular_JJ survival_NN ,_,
          while_IN the_DT IL-_NNP 2_CD regulation_NN of_IN the_DT other_JJ three_CD genes_NNS would_MD
          be_VB expected_VBN to_TO promote_VB apoptosis_NNS ._. Additional_JJ
          IL-_NNP 2_CD -_: responsive_JJ genes_NNS include_VBP those_DT encoding_VBG 6_CD cell_NN
          surface_NN proteins_NNS ,_, 11_CD cytokine_NN and_CC chemokine_NN receptors_NNS ,_, as_RB
          well_RB as_IN 15_CD signal_NN transduction_NN mediators_NNS ,_, 6_CD genes_NNS
          involved_VBN in_IN cellular_JJ metabolism_NN and_CC biosynthesis_NNS ,_, 3_CD cell_NN
          cycle_NN regulators_NNS and_CC 12_CD transcription_NN factors_NNS ._.
          IL-_NNP 2_CD -_: suppressed_VBN genes_NNS include_VBP lymphocyte_NN antigen_NN 9_CD ,_,
          inositol_NN 1_CD ,_, 4_CD ,_, 5_CD -_: trisphosphate_NN 3_CD -_: kinase_NN B_NNP ,_, and_CC cdc_NN 25_CD B_NNP ,_, as_RB
          well_RB as_IN transcriptional_NN regulators_NNS MAX-interacting_NNP
          protein_NN 1_CD ,_, CBP_NNP /_NN p_NN 300_CD -_: interacting_VBG transactivator_NN ,_, inhibitor_NN
          of_IN DNA_NNP binding_JJ 3_CD (_( Id_NN 3_LS )_) ,_, glucocorticoid-induced_JJ leucine_NN
          zipper_NN (_( GILZ_NNP )_) ,_, and_CC zinc_NN finger_NN protein_NN 36_CD /_NN ERF-_NNP 2_CD ._. All_DT of_IN
          the_DT 19_CD already_RB known_VBN IL-_NNP 2_CD -_: regulated_VBN genes_NNS (_( Table_NNP 2_LS )_) were_VBD
          also_RB identified_VBN in_IN this_DT 72_CD -_: gene_NN cohort_NN ,_, thereby_RB yielding_VBG
          53_CD newly_RB identified_VBN IL-_NNP 2_CD -_: regulated_VBN genes_NNS expressed_VBN by_IN
          PBMCs_NNP after_IN 4_CD hours_NNS of_IN IL-_NNP 2_CD stimulation_NN ._.
        
        
          IL-_NNP 2_CD -_: regulated_VBN immediate_JJ /_NN early_JJ genes_NNS in_IN T_NN
          cells_NNS
          The_DT PBMC_NNP populations_NNS used_VBN in_IN our_PRP$ initial_JJ experiments_NNS
          included_VBD NK_NNP cells_NNS ,_, monocytes_NNS and_CC B_NNP cells_NNS ,_, as_RB well_RB as_IN T_NN
          cells_NNS ._. In_IN addition_NN ,_, cytokines_NNS including_VBG TNFα_NNP ,_, TNFβ_NNP and_CC
          flt_NN 3_CD ligand_NN were_VBD induced_VBN by_IN IL-_NNP 2_CD as_IN detected_VBN by_IN the_DT
          arrays_NNS ,_, so_IN that_IN the_DT IL-_NNP 2_CD effects_NNS could_MD be_VB mediated_JJ by_IN the_DT
          action_NN of_IN these_DT intermediary_JJ cytokines_NNS on_IN other_JJ cells_NNS in_IN
          the_DT mixed_JJ population_NN ,_, or_CC as_IN well_RB ,_, by_IN the_DT 12_CD
          transcriptional_NN targets_NNS activated_VBN by_IN IL-_NNP 2_CD ._. Therefore_RB to_TO
          identify_VB the_DT direct_JJ IL-_NNP 2_CD targets_NNS in_IN T_NN cells_NNS ,_, we_PRP used_VBD
          CD_NNP 56_CD -_: depleted_VBN ,_, CD_NNP 2_CD -_: selected_VBN T_NN cells_NNS ,_, which_WDT were_VBD 94_CD ±_NN 1_CD %_NN
          CD_NNP 3_CD +_NN cells_NNS ._. The_DT PBMCs_NNP were_VBD pre-activated_JJ with_IN anti-_NN CD_NNP 3_CD
          for_IN 72_CD hr_NN ,_, the_DT T_NN cells_NNS purified_JJ ,_, and_CC rested_VBD for_IN 36_CD -_: 40_CD hr_NN
          prior_RB to_TO restimulation_NN for_IN 4_CD hr_NN with_IN 1_CD nM_NN IL-_NNP 2_CD ._. In_IN
          addition_NN ,_, 10_CD μg_NN /_NN mL_NN cycloheximide_NN (_( CHX_NNP )_) was_VBD included_VBN to_TO
          block_VB protein_NN synthesis_NN ,_, so_IN that_IN only_RB immediate_JJ /_NN early_JJ
          IL-_NNP 2_CD -_: regulated_VBN genes_NNS were_VBD detected_VBN ._. CHX_NNP has_VBZ been_VBN shown_VBN to_TO
          both_DT elevate_NN and_CC prolong_VB the_DT expression_NN of_IN many_JJ
          transiently_RB induced_VBN transcripts_NNS [_NN 26_CD 29_CD ]_NN ,_, so_IN that_IN the_DT 4_CD
          hr_NN IL-_NNP 2_CD stimulation_NN in_IN the_DT presence_NN of_IN CHX_NNP should_MD enable_VB
          detection_NN of_IN genes_NNS induced_VBN within_IN minutes_NNS as_RB well_RB as_IN
          hours_NNS ._. Samples_NNP from_IN 4_CD independent_JJ experiments_NNS with_IN
          pre-activated_JJ ,_, rested_VBD cells_NNS ,_, or_CC cells_NNS treated_VBN with_IN CHX_NNP
          alone_RB were_VBD combined_VBN for_IN data_NNS analysis_NN ,_, and_CC compared_VBD to_TO
          cells_NNS treated_VBN with_IN IL-_NNP 2_CD ±_NN CHX_NNP ._.
          As_IN depicted_VBN in_IN Figure_NN 2_CD A_DT ,_, using_VBG only_RB the_DT criterion_NN of_IN
          significance_NN level_NN of_IN p_NN <_NN 0_CD ._. 05_CD for_IN the_DT difference_NN
          between_IN the_DT means_NNS of_IN the_DT two_CD groups_NNS ,_, 449_CD probe_NN sets_NNS were_VBD
          identified_VBN as_IN IL-_NNP 2_CD -_: regulated_VBN immediate-early_JJ targets_NNS in_IN
          the_DT pure_JJ T_NN cells_NNS ._. Of_IN these_DT probe_NN sets_NNS ,_, 110_CD were_VBD also_RB
          detected_VBN in_IN the_DT IL-_NNP 2_CD -_: stimulated_VBN PBMCs_NNP ._. As_IN shown_VBN in_IN Figure_NN
          2_CD B_NNP ,_, when_WRB a_DT second_JJ standard_NN was_VBD included_VBN ,_, either_CC a_DT fold_VB
          change_NN ≥_NN 2_CD ,_, or_CC a_DT subtracted_VBN difference_NN ≥_NN 100_CD ,_, 161_CD probe_NN
          sets_NNS (_( 36_CD %_NN )_) were_VBD expressed_VBN as_RB immediately_RB /_NN early_JJ genes_NNS in_IN
          purified_JJ T_NN cells_NNS ,_, and_CC of_IN these_DT ,_, 71_CD were_VBD also_RB
          IL-_NNP 2_CD -_: regulated_VBN in_IN PBMCs_NNP ._. However_RB ,_, when_WRB all_DT 3_CD criteria_NNS
          were_VBD applied_VBN (_( Figure_NN 2_CD C_NNP )_) ,_, a_DT total_NN of_IN only_RB 52_CD probe_NN sets_NNS
          (_( 12_CD %_NN )_) were_VBD found_VBN to_TO be_VB immediate_JJ /_NN early_JJ ,_, IL-_NNP 2_CD -_: regulated_VBN
          genes_NNS in_IN T_NN cells_NNS ._. Twenty-three_NNP of_IN these_DT 52_CD probe_NN sets_NNS
          were_VBD among_IN the_DT 84_CD probe_NN sets_NNS identified_VBN previously_RB as_IN
          meeting_VBG all_DT 3_CD criteria_NNS in_IN the_DT experiments_NNS with_IN PBMCs_NNP
          (_( Figure_NN 3_LS )_) ._. By_IN comparison_NN ,_, the_DT control_NN genes_NNS actin_NN and_CC
          GAPDH_NNP showed_VBD 1_CD ._. 1_CD ±_NN 0_CD ._. 1_CD and_CC 1_CD ._. 3_CD ±_NN 0_CD ._. 2_CD -_: fold_VB change_NN ,_,
          respectively_RB ._.
          The_DT 23_CD probe_NN sets_NNS represent_VBP 20_CD IL-_NNP 2_CD -_: regulated_VBN
          immediate_JJ /_NN early_JJ genes_NNS ._. Therefore_RB ,_, only_RB ~_NN 1_CD /_NN 3_CD of_IN the_DT genes_NNS
          discovered_VBN to_TO be_VB IL-_NNP 2_CD -_: regulated_VBN in_IN PBMCs_NNP are_VBP actually_RB
          immediate_JJ /_NN early_JJ direct_JJ IL-_NNP 2_CD targets_NNS in_IN T_NN cells_NNS ._. These_DT
          direct_JJ IL-_NNP 2_CD immediate_JJ /_NN early_JJ target_NN genes_NNS included_VBD 4_CD genes_NNS
          that_WDT were_VBD suppressed_VBN ,_, DSIP_NNP /_NN GILZ_NNP ,_, the_DT zinc_NN finger_NN protein_NN
          36_CD /_NN ERF-_NNP 2_CD /_NN Tis_NNP 11_CD d_SYM ,_, Toso_NNP ,_, and_CC cdc_NN 25_CD B_NNP ._. Notably_RB ,_, of_IN the_DT 16_CD
          IL-_NNP 2_CD -_: induced_VBN genes_NNS ,_, we_PRP had_VBD already_RB been_VBN identified_VBN 4_CD
          previously_RB as_IN IL-_NNP 2_CD targets_NNS using_VBG differential_NN colony_NN
          hybridization_NN (_( CR_NNP 3_CD ,_, CR_NNP 6_CD ,_, CR_NNP 7_CD ,_, CR_NNP 8_CD )_) [_NN 29_CD ]_NN ,_, while_IN the_DT 3_CD
          other_JJ known_VBN IL-_NNP 2_CD stimulated_VBN target_NN genes_NNS included_VBD TNFβ_NNP ,_,
          the_DT IL-_NNP 4_CD R_NN ,_, and_CC the_DT anti-apoptotic_JJ gene_NN ,_, Bcl_NNP 2_CD ._. Thus_RB ,_, only_RB
          9_CD genes_NNS were_VBD newly_RB identified_VBN as_IN IL-_NNP 2_CD -_: induced_VBN
          immediate_JJ /_NN early_JJ T_NN cell_NN genes_NNS ;_: including_VBG the_DT signaling_VBG
          proteins_NNS SLP_NNP 76_CD and_CC RGS_NNP 1_CD ,_, the_DT transcription_NN factors_NNS IRF_NNP 4_CD
          and_CC XBP_NNP 1_CD ,_, and_CC 5_CD miscellaneous_JJ genes_NNS (_( DKFZp_NNP 586_CD F_NN 1323_CD ,_,
          mitofilin_NN ,_, cAMP-specific_JJ phosphodiesterase_NN 4_CD B_NNP ,_,
          CMP-N-acetylneuraminate_NNP monooxygenase_NN ,_, and_CC the_DT aryl_NN
          hydrocarbon_NN receptor_NN )_) ._.
          In_IN addition_NN to_TO the_DT 23_CD probe_NN sets_NNS in_IN common_JJ with_IN those_DT
          identified_VBN in_IN PBMCs_NNP ,_, 29_CD others_NNS were_VBD detected_VBN as_IN
          IL-_NNP 2_CD -_: regulated_VBN immediate_JJ /_NN early_JJ targets_NNS in_IN the_DT purified_JJ T_NN
          cells_NNS (_( Figure_NN 2_CD C_NNP )_) ._. These_DT probe_NN sets_NNS met_VBD all_DT three_CD of_IN the_DT
          criteria_NNS of_IN ≥_NN 2_CD -_: fold_VB change_NN ,_, subtracted_VBN difference_NN ≥_NN 100_CD ,_,
          and_CC p_NN <_NN 0_CD ._. 05_CD in_IN T_NN cells_NNS ,_, but_CC were_VBD not_RB IL-_NNP 2_CD -_: regulated_VBN
          in_IN PBMCs_NNP ._. These_DT probe_NN sets_NNS represent_VBP 27_CD unique_JJ genes_NNS ,_, and_CC
          are_VBP presented_VBN in_IN Figure_NN 4_CD ._. Notably_RB ,_, only_RB three_CD of_IN these_DT
          were_VBD induced_VBN ,_, while_IN the_DT remaining_VBG 24_CD were_VBD all_DT suppressed_VBN
          in_IN response_NN to_TO IL-_NNP 2_CD +_NN CHX_NNP ._.
          Of_IN the_DT remaining_VBG 61_CD probe_NN sets_NNS identified_VBN in_IN PBMCs_NNP
          (_( Figure_NN 2_CD C_NNP )_) ,_, 31_CD showed_VBD changes_NNS in_IN expression_NN levels_NNS in_IN T_NN
          cells_NNS with_IN p_NN <_NN 0_CD ._. 05_CD ,_, although_IN either_DT the_DT fold_VB change_NN
          was_VBD less_JJR than_IN 2_CD ._. 0_CD ,_, or_CC the_DT magnitude_NN of_IN the_DT change_NN was_VBD
          less_JJR than_IN 100_CD (_( Table_NNP 3_LS )_) ._. These_DT 31_CD probe_NN sets_NNS are_VBP derived_VBN
          from_IN 27_CD unique_JJ genes_NNS ,_, and_CC most_RBS likely_JJ represent_VB bona_JJ fide_JJ
          IL-_NNP 2_CD targets_NNS ,_, since_IN the_DT group_NN includes_VBZ the_DT genes_NNS
          JAB_NNP /_NN SSI-_NNP 1_CD /_NN SOCS-_NNP 1_CD ,_, flt_NN 3_CD ligand_NN ,_, IL-_NNP 2_CD Rp_NNP 55_CD ,_, caspase_NN 3_CD ,_, and_CC
          p_NN 78_CD ,_, which_WDT have_VBP already_RB been_VBN reported_VBN as_IN IL-_NNP 2_CD -_: induced_VBN
          genes_NNS ._. If_IN these_DT genes_NNS are_VBP also_RB included_VBN ,_, 47_CD of_IN the_DT 72_CD
          unique_JJ genes_NNS (_( 65_CD %_NN )_) identified_VBN in_IN PBMCs_NNP are_VBP IL-_NNP 2_CD -_: regulated_VBN
          immediate_JJ /_NN early_JJ genes_NNS in_IN pure_JJ T_NN cells_NNS ._.
          Similarly_RB ,_, of_IN the_DT 29_CD probe_NN sets_NNS identified_VBN as_IN meeting_VBG
          all_DT 3_CD criteria_NNS only_RB in_IN pure_JJ T_NN cells_NNS ,_, 7_CD showed_VBD differences_NNS
          in_IN expression_NN with_IN p_NN <_NN 0_CD ._. 05_CD in_IN PBMCs_NNP (_( Table_NNP 4_LS )_) ._. These_DT
          include_VBP linker_NN for_IN activation_NN of_IN T_NN cells_NNS ,_, T-_NNP cell-specific_JJ
          transcription_NN factor_NN 7_CD ,_, STAT_NNP 4_CD ,_, IL-_NNP 7_CD R_NN ,_, PAS_NNP ser_NN /_NN thr_NN kinase_NN ,_,
          l-mfa_JJ domain-containing_JJ protein_NN ,_, and_CC an_DT unknown_JJ gene_NN
          designated_VBN DKFZp_NNP 586_CD D_NNP 1122_CD ._. Notably_RB ,_, all_DT of_IN the_DT other_JJ genes_NNS
          (_( 22_CD )_) were_VBD suppressed_VBN by_IN IL-_NNP 2_CD in_IN the_DT PBMCs_NNP ,_, as_IN they_PRP were_VBD
          in_IN the_DT T_NN cells_NNS ,_, although_IN they_PRP did_VBD not_RB meet_VB the_DT
          significance_NN value_NN of_IN p_NN <_NN 0_CD ._. 05_CD in_IN the_DT PBMCs_NNP ._.
        
      
      
        Discussion_NNP
        Lymphocyte_NNP activation_NN is_VBZ initiated_VBN by_IN specific_JJ
        antigen_NN /_NN receptor_NN interactions_NNS ,_, and_CC aided_VBN by_IN accessory_JJ
        molecules_NNS ._. However_RB subsequently_RB ,_, cytokine_NN and_CC cytokine_NN
        receptor_NN expression_NN ensue_VB ,_, and_CC the_DT cytokines_NNS ultimately_RB
        drive_VBP the_DT clonal_NN expansion_NN and_CC functional_JJ differentiation_NN
        of_IN the_DT antigen-selected_JJ lymphocyte_NN populations_NNS ._. IL-_NNP 2_CD was_VBD
        initially_RB identified_VBN by_IN virtue_NN of_IN its_PRP$ T_NN cell_NN growth_NN factor_NN
        activity_NN ,_, and_CC IL-_NNP 2_CD is_VBZ now_RB recognized_VBN as_IN the_DT pivotal_JJ
        cytokine_NN in_IN promoting_VBG mature_VBP peripheral_JJ T_NN cell_NN
        proliferation_NN [_NN 36_CD 37_CD ]_NN ._. Therefore_RB ,_, to_TO initiate_VB the_DT
        identification_NN of_IN the_DT genes_NNS responsible_JJ for_IN lymphocyte_NN
        activation_NN ,_, we_PRP chose_VBD first_JJ to_TO delineate_NN the_DT genetic_JJ
        mechanisms_NNS of_IN IL-_NNP 2_CD action_NN ._. Using_VBG oligonucleotide_NN arrays_NNS of_IN
        known_VBN genes_NNS to_TO identify_VB IL-_NNP 2_CD -_: regulated_VBN genes_NNS in_IN human_JJ
        lymphocytes_NNS ,_, a_DT total_NN of_IN 72_CD unique_JJ genes_NNS were_VBD found_VBN to_TO
        change_VB expression_NN within_IN 4_CD hr_NN of_IN IL-_NNP 2_CD stimulation_NN of_IN PBMCs_NNP ._.
        These_DT genes_NNS could_MD be_VB segregated_VBD into_IN functional_JJ groups_NNS ,_,
        including_VBG cell_NN surface_NN proteins_NNS ,_, cytokine_NN and_CC chemokine_NN
        receptors_NNS ,_, as_RB well_RB as_IN signal_NN transduction_NN mediators_NNS ,_,
        cytokines_NNS ,_, genes_NNS involved_VBN in_IN cellular_JJ metabolism_NN and_CC
        biosynthesis_NNS ,_, cell_NN cycle_NN regulators_NNS and_CC transcription_NN
        factors_NNS ._.
        In_IN order_NN to_TO define_VB the_DT criteria_NNS that_IN we_PRP used_VBD to_TO sort_VB the_DT
        microarray_NN data_NN in_IN this_DT series_NN of_IN experiments_NNS ,_, we_PRP were_VBD able_JJ
        to_TO take_VB advantage_NN of_IN previous_JJ reports_NNS of_IN 19_CD known_VBN
        IL-_NNP 2_CD -_: regulated_VBN genes_NNS ._. By_IN assessing_VBG the_DT characteristics_NNS of_IN
        the_DT changes_NNS in_IN expression_NN of_IN these_DT known_VBN IL-_NNP 2_CD targets_NNS ,_, we_PRP
        were_VBD able_JJ to_TO define_VB a_DT range_NN of_IN both_DT fold-induction_JJ and_CC
        subtracted_VBN difference_NN that_WDT encompassed_VBD all_DT of_IN these_DT genes_NNS ._.
        When_WRB applied_VBN to_TO the_DT total_JJ data_NN set_VBN ,_, these_DT criteria_NNS were_VBD
        likely_JJ to_TO identify_VB additional_JJ meaningful_JJ IL-_NNP 2_CD -_: regulated_VBN
        genes_NNS ._. Since_IN 19_CD of_IN these_DT genes_NNS had_VBD already_RB been_VBN reported_VBN to_TO
        be_VB IL-_NNP 2_CD -_: induced_VBN genes_NNS ,_, our_PRP$ DNA_NNP array_NN experiments_NNS identified_VBD
        53_CD additional_JJ IL-_NNP 2_CD -_: regulated_VBN genes_NNS expressed_VBN by_IN PBMCs_NNP ._.
        However_RB ,_, only_RB 20_CD of_IN these_DT genes_NNS were_VBD found_VBN to_TO be_VB
        IL-_NNP 2_CD -_: regulated_VBN immediate_JJ /_NN early_JJ T_NN cell_NN genes_NNS ._.
        It_PRP is_VBZ important_JJ to_TO discriminate_JJ these_DT results_NNS from_IN other_JJ
        analyses_NNS of_IN T_NN cell_NN activation_NN that_WDT have_VBP employed_VBN antigen_NN
        receptor_NN activation_NN ,_, as_IN opposed_VBN to_TO IL-_NNP 2_CD ._. The_DT TCR_NNP and_CC IL-_NNP 2_CD
        receptors_NNS activate_VBP some_DT shared_VBN signaling_VBG pathways_NNS ,_, such_JJ as_IN
        the_DT Ras-_NNP Raf-_NNP MAP_NNP kinase_NN and_CC PI-_NNP 3_CD -_: kinase_NN pathways_NNS [_NN 38_CD ]_NN ._.
        However_RB ,_, there_EX are_VBP differences_NNS ,_, such_JJ as_IN the_DT Jak-_NNP Stat_NNP
        pathway_NN ,_, which_WDT is_VBZ unique_JJ to_TO the_DT cytokines_NNS [_NN 39_CD ]_NN ,_, and_CC the_DT
        Ca_MD +_NN +_NN /_NN Calcineurin_NNP pathway_NN ,_, which_WDT is_VBZ activated_VBN by_IN the_DT TCR_NNP ._.
        These_DT signaling_VBG pathways_NNS culminate_NN in_IN the_DT activation_NN of_IN
        specific_JJ transcription_NN factors_NNS ,_, so_IN that_IN there_EX must_MD be_VB both_DT
        shared_VBN target_NN genes_NNS ,_, as_RB well_RB as_IN genes_NNS unique_JJ to_TO antigen_NN or_CC
        IL-_NNP 2_CD signaling_VBG ._. As_IN TCR_NNP signaling_VBG induces_VBZ the_DT expression_NN of_IN
        IL-_NNP 2_CD ,_, as_RB well_RB as_IN other_JJ cytokines_NNS and_CC their_PRP$ receptors_NNS ,_, the_DT
        ultimate_JJ T_NN cell_NN response_NN is_VBZ an_DT amalgam_NN of_IN both_DT antigen-_NN and_CC
        cytokine_NN receptor-triggered_JJ events_NNS ._.
        This_DT point_NN is_VBZ well_RB illustrated_VBN by_IN the_DT report_NN of_IN Teague_NNP
        et_CC al_NN [_NN 40_CD ]_NN ,_, who_WP used_VBD microarrays_NNS to_TO identify_VB murine_NN T_NN
        cell_NN genes_NNS induced_VBN 
        in_IN vivo_NN by_IN SEB_NNP stimulation_NN after_IN 8_CD
        and_CC 48_CD hours_NNS ._. Again_RB ,_, cytokine_NN and_CC cytokine_NN receptor_NN genes_NNS
        were_VBD induced_VBN during_IN these_DT time_NN intervals_NNS ,_, so_IN that_IN the_DT
        entire_JJ spectrum_NN of_IN genes_NNS identified_VBN included_VBD both_DT antigen-_NN
        and_CC accessory_JJ molecule-activated_JJ ,_, as_RB well_RB as_IN
        cytokine-regulated_JJ targets_NNS ._. Similarly_RB ,_, Ellisen_NNP et_CC al_NN [_NN 41_CD ]_NN
        used_VBD DNA_NNP arrays_NNS to_TO monitor_VB ConA-induced_NNP genes_NNS in_IN human_JJ T_NN
        lymphocytes_NNS ,_, over_IN a_DT time_NN scale_NN ranging_VBG from_IN 4_CD to_TO 48_CD hours_NNS ._.
        Inducible_NNP genes_NNS included_VBD IL-_NNP 2_CD and_CC TNF-α_NNP ,_, as_RB well_RB as_IN the_DT
        IL-_NNP 1_CD R_NN ,_, IL-_NNP 2_CD Rα_NNP and_CC IL-_NNP 4_CD R_NN ._. Thus_RB ,_, at_IN the_DT time_NN points_NNS used_VBN in_IN
        this_DT study_NN ,_, many_JJ of_IN the_DT genes_NNS detected_VBD were_VBD likely_RB
        regulated_VBN by_IN these_DT cytokines_NNS as_RB well_RB as_IN Con_NN A_DT ._. In_IN a_DT similar_JJ
        vein_NN ,_, Herblot_NNP et_CC al_NN [_NN 42_CD ]_NN used_VBD a_DT subtractive_JJ approach_NN to_TO
        identify_VB 66_CD genes_NNS induced_VBN by_IN IL-_NNP 2_CD but_CC not_RB IL-_NNP 4_CD in_IN a_DT murine_NN
        T_NN cell_NN line_NN ._. They_PRP further_RBR demonstrated_VBN that_IN while_IN 
        in_IN vitro_NN ,_, ConA_NNP could_MD induce_VB
        expression_NN of_IN the_DT IL-_NNP 2_CD target_NN genes_NNS in_IN T_NN cells_NNS from_IN IL-_NNP 2_CD
        +_NN /_NN +_NN mice_NNS ,_, the_DT genes_NNS were_VBD not_RB induced_VBN by_IN ConA_NNP treatment_NN of_IN T_NN
        cells_NNS from_IN IL-_NNP 2_CD -_: /_NN -_: mice_NNS ._. Thus_RB ,_, ConA_NNP induces_VBZ IL-_NNP 2_CD and_CC IL-_NNP 2_CD R_NN
        expression_NN ,_, and_CC the_DT cytokine_NN drives_NNS expression_NN of_IN
        additional_JJ specific_JJ target_NN genes_NNS ._. Recently_RB ,_, Riley_NNP et_CC al_NN [_NN
        43_CD ]_NN and_CC Diehn_NNP et_CC al_NN [_NN 44_CD ]_NN described_VBD genes_NNS regulated_VBN by_IN
        the_DT TCR_NNP and_CC the_DT costimulatory_NN receptors_NNS CD_NNP 28_CD ,_, ICOS_NNP and_CC
        CTLA-_NNP 4_CD ,_, over_IN a_DT time_NN course_NN of_IN 1_CD -_: 48_CD hours_NNS ._. Once_RB again_RB ,_,
        numerous_JJ cytokines_NNS ,_, including_VBG IL-_NNP 2_CD ,_, are_VBP strongly_RB induced_VBN
        within_IN 2_CD hr_NN ,_, such_JJ that_IN a_DT number_NN of_IN the_DT observed_VBN regulated_VBN
        genes_NNS are_VBP likely_JJ cytokine-responsive_JJ targets_NNS ._. Finally_RB ,_,
        Gonzalez_NNP et_CC al_NN [_NN 45_CD ]_NN have_VBP described_VBN murine_NN genes_NNS induced_VBN
        after_IN 8_CD hr_NN IL-_NNP 2_CD stimulation_NN ,_, which_WDT likely_JJ include_VBP direct_JJ
        targets_NNS of_IN IL-_NNP 2_CD ,_, as_RB well_RB as_IN genes_NNS induced_VBN via_IN IL-_NNP 2_CD -_:
        regulated_VBN cytokines_NNS ._.
        Therefore_RB ,_, to_TO discriminate_JJ between_IN the_DT distinct_JJ genes_NNS
        induced_VBN by_IN each_DT ligand_NN that_WDT contributes_VBZ to_TO the_DT overall_JJ
        response_NN initiated_VBN by_IN antigenic_JJ stimulation_NN ,_, it_PRP is_VBZ
        important_JJ to_TO use_VB cycloheximide_NN to_TO identify_VB immediate_JJ /_NN early_JJ
        genes_NNS regulated_VBN by_IN the_DT TCR_NNP and_CC costimulatory_NN receptors_NNS vs_NNS ._.
        IL-_NNP 2_CD ._. In_IN addition_NN ,_, the_DT genes_NNS activated_VBN by_IN TCR_NNP ,_,
        costimulatory_NN receptors_NNS and_CC IL-_NNP 2_CD must_MD be_VB distinguished_VBN from_IN
        those_DT activated_VBN by_IN IL-_NNP 1_CD ,_, IL-_NNP 6_CD ,_, IL-_NNP 12_CD ,_, and_CC TNF-α_NNP ,_, as_RB well_RB as_IN
        the_DT genes_NNS regulated_VBN by_IN the_DT Toll-like_NNP receptors_NNS (_( TLR_NNP )_) ,_, all_DT
        of_IN which_WDT have_VBP been_VBN identified_VBN as_IN mediators_NNS of_IN lymphocyte_NN
        activation_NN events_NNS that_WDT were_VBD previously_RB ascribed_VBN to_TO LAF_NNP ._.
        Moreover_RB ,_, as_IN IL-_NNP 2_CD itself_PRP induces_VBZ the_DT expression_NN of_IN numerous_JJ
        cytokines_NNS and_CC receptors_NNS ,_, it_PRP is_VBZ important_JJ to_TO discriminate_JJ
        the_DT direct_JJ IL-_NNP 2_CD targets_NNS from_IN those_DT induced_VBN secondarily_RB
        through_IN these_DT intermediaries_NNS ._. Thus_RB ,_, it_PRP is_VBZ worthy_JJ of_IN
        re-emphasis_JJ that_IN of_IN the_DT 72_CD genes_NNS regulated_VBN by_IN IL-_NNP 2_CD in_IN
        PBMCs_NNP ,_, only_RB 20_CD were_VBD found_VBN to_TO be_VB bona_JJ fide_JJ IL-_NNP 2_CD -_: regulated_VBN
        immediate_JJ /_NN early_JJ genes_NNS in_IN purified_JJ T_NN cells_NNS ._.
        In_IN addition_NN to_TO imparting_VBG positive_JJ activating_VBG signals_NNS
        that_WDT result_NN in_IN cell_NN cycle_NN progression_NN ,_, IL-_NNP 2_CD has_VBZ also_RB been_VBN
        found_VBN to_TO promote_VB negative_JJ feedback_NN phenomena_NNS ._. Thus_RB ,_, it_PRP is_VBZ
        especially_RB intriguing_JJ that_IN IL-_NNP 2_CD suppresses_NNS the_DT expression_NN
        of_IN many_JJ genes_NNS ,_, both_DT among_IN PBMCs_NNP in_IN the_DT absence_NN of_IN CHX_NNP ,_, as_RB
        well_RB as_IN in_IN purified_JJ T_NN cells_NNS in_IN the_DT presence_NN of_IN CHX_NNP ._. The_DT
        suppression_NN of_IN the_DT expression_NN of_IN these_DT genes_NNS may_MD well_RB be_VB
        important_JJ in_IN mediating_VBG the_DT feedback_NN down-regulatory_JJ
        phenomena_NNS ._.
        The_DT high-affinity_JJ IL-_NNP 2_CD receptor_NN is_VBZ comprised_VBN of_IN three_CD
        subunits_NNS ,_, α_NN ,_, β_NN and_CC γ_NN [_NN 46_CD 47_CD ]_NN ._. The_DT α_NN chain_NN is_VBZ specific_JJ to_TO
        IL-_NNP 2_CD ,_, while_IN the_DT γ_NN chain_NN is_VBZ shared_VBN among_IN IL-_NNP 4_CD ,_, IL-_NNP 7_CD ,_, IL-_NNP 9_CD ,_,
        IL-_NNP 15_CD and_CC IL-_NNP 21_CD [_NN 48_CD ]_NN ._. The_DT β_NN chain_NN of_IN the_DT IL-_NNP 2_CD R_NN is_VBZ also_RB a_DT
        component_NN of_IN the_DT IL-_NNP 15_CD receptor_NN ,_, in_IN conjunction_NN with_IN a_DT
        specific_JJ IL-_NNP 15_CD R_NN α_NN chain_NN [_NN 49_CD ]_NN ._. The_DT sharing_NN of_IN these_DT
        receptors_NNS by_IN multiple_JJ cytokines_NNS raises_VBZ the_DT question_NN of_IN how_WRB
        the_DT ligands_NNS can_MD trigger_VB specific_JJ responses_NNS in_IN the_DT target_NN
        cells_NNS ._. Several_JJ signaling_VBG events_NNS ,_, including_VBG the_DT activation_NN
        of_IN Jak_NNP kinases_NNS 1_CD and_CC 3_CD are_VBP shared_VBN among_IN the_NNP '_POS common_JJ γ_NN
        chain_NN '_'' cytokines_NNS [_NN 50_CD ]_NN ._. Other_JJ signaling_VBG events_NNS ,_, such_JJ as_IN
        the_DT activation_NN of_IN Shc_NNP ,_, Gab_NNP 2_CD ,_, SHP-_NNP 2_CD and_CC MAPK_NNP ,_, are_VBP shared_VBN
        among_IN IL-_NNP 2_CD and_CC 15_CD ,_, but_CC not_RB the_DT other_JJ common_JJ γ_NN chain_NN
        cytokine_NN receptors_NNS ,_, and_CC Tyr_NNP 388_CD of_IN IL-_NNP 2_CD Rβ_NNP appears_VBZ critical_JJ
        for_IN these_DT events_NNS [_NN 51_CD ]_NN ._. Despite_IN these_DT signaling_VBG
        similarities_NNS ,_, it_PRP is_VBZ clear_JJ that_IN the_DT biological_JJ properties_NNS of_IN
        IL-_NNP 2_CD are_VBP unique_JJ among_IN the_DT common_JJ γ_NN chain_NN cytokines_NNS ,_, as_IN the_DT
        other_JJ cytokines_NNS cannot_NN compensate_VB for_IN IL-_NNP 2_CD in_IN the_DT IL-_NNP 2_CD
        knockout_NN mouse_NN [_NN 52_CD ]_NN ._. In_IN addition_NN ,_, IL-_NNP 15_CD appears_VBZ uniquely_RB
        critical_JJ for_IN the_DT development_NN of_IN NK_NNP cells_NNS ,_, as_IN evidenced_VBN by_IN
        the_DT phenotypes_NNS of_IN IL-_NNP 15_CD [_NN 53_CD ]_NN and_CC IL-_NNP 15_CD R_NN α_NN [_NN 54_CD ]_NN
        deficient_NN mice_NNS ._. Thus_RB ,_, there_EX must_MD be_VB a_DT means_NN whereby_WRB IL-_NNP 2_CD
        and_CC IL-_NNP 15_CD ,_, as_RB well_RB as_IN the_DT other_JJ common_JJ γ_NN chain_NN cytokines_NNS ,_,
        trigger_VB distinct_JJ intracellular_NN signaling_VBG pathways_NNS ,_, and_CC
        target_NN genes_NNS ._. Therefore_RB ,_, identification_NN of_IN each_DT of_IN the_DT
        cytokine-specific_JJ target_NN genes_NNS should_MD shed_VB light_JJ on_IN the_DT
        issue_NN of_IN specificity_NN amongst_IN the_DT common_JJ γ_NN chain_NN
        cytokines_NNS ._.
        Complete_JJ classification_NN of_IN the_DT genes_NNS expressed_VBD as_IN a_DT
        consequence_NN of_IN distinct_JJ ligand_NN /_NN receptor_NN interactions_NNS during_IN
        lymphocyte_NN activation_NN will_MD also_RB provide_VB a_DT powerful_JJ tool_NN for_IN
        the_DT assessment_NN and_CC treatment_NN of_IN immunological_JJ disorders_NNS [_NN
        55_CD ]_NN ._. In_IN addition_NN to_TO defining_VBG the_DT target_NN genes_NNS of_IN specific_JJ
        cytokines_NNS and_CC cell_NN surface_NN ligands_NNS ,_, it_PRP is_VBZ possible_JJ to_TO
        further_VB subdivide_NN the_DT genes_NNS based_VBN on_IN the_DT specific_JJ signaling_VBG
        proteins_NNS and_CC transcription_NN factors_NNS that_WDT govern_VBP their_PRP$
        expression_NN ._. For_IN example_NN ,_, through_IN the_DT use_NN of_IN STAT_NNP 5_CD -_: /_NN -_: mice_NNS ,_,
        Ihle_NNP et_CC al_NN have_VBP been_VBN able_JJ to_TO identify_VB those_DT IL-_NNP 2_CD target_NN
        genes_NNS that_WDT require_VBP STAT_NNP 5_CD [_NN 56_CD 57_CD ]_NN ._. Similar_JJ approaches_NNS
        with_IN mutant_JJ signaling_VBG proteins_NNS ,_, knockouts_NNS ,_, or_CC
        over-expression_JJ systems_NNS enable_VBP such_JJ dissection_NN of_IN the_DT
        signal_NN transduction_NN pathways_NNS leading_VBG to_TO specific_JJ target_NN
        genes_NNS ._. Thus_RB ,_, each_DT ligand_NN /_NN receptor_NN pair_NN will_MD ultimately_RB be_VB
        linked_VBN to_TO a_DT specific_JJ signature_NN of_IN target_NN genes_NNS ,_, derived_VBN
        from_IN the_DT signaling_VBG pathways_NNS and_CC transcription_NN factors_NNS
        activated_VBN ._. Such_JJ information_NN will_MD be_VB invaluable_JJ in_IN the_DT
        diagnosis_NN and_CC treatment_NN of_IN disorders_NNS involving_VBG aberrancies_NNS
        in_IN these_DT pathways_NNS ._.
      
      
        Conclusions_NNP
        The_DT rapidity_NN with_IN which_WDT lymphocyte_NN activation_NN genes_NNS may_MD
        now_RB be_VB identified_VBN using_VBG the_DT methods_NNS described_VBD in_IN this_DT
        report_NN opens_VBZ the_DT way_NN to_TO a_DT molecular_JJ genetic_JJ definition_NN of_IN
        the_DT immune_JJ response_NN ,_, based_VBN upon_IN the_DT categorization_NN of_IN the_DT
        genes_NNS regulated_VBN by_IN distinct_JJ ligand_NN receptor_NN pairs_NNS ._.
        Consequently_RB ,_, more_RBR precise_JJ genetic_JJ and_CC molecular_JJ diagnoses_NNS
        of_IN immune_JJ disorders_NNS will_MD soon_RB become_VB available_JJ ,_, and_CC
        hopefully_RB ,_, new_JJ treatment_NN regimes_NNS may_MD be_VB developed_VBN to_TO target_VB
        the_DT specific_JJ molecular_JJ nature_NN of_IN each_DT disease_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Cell_NNP culture_NN
          Human_NNP peripheral_JJ blood_NN mononuclear_NN cells_NNS (_( PBMC_NNP )_) were_VBD
          purified_JJ from_IN venous_JJ blood_NN of_IN healthy_JJ donors_NNS by_IN density_NN
          centrifugation_NN over_IN Histopaque_NNP 1_CD ._. 077_CD (_( Sigma_NNP )_) ._. Cells_NNP were_VBD
          cultured_JJ in_IN RPMI_NNP 1640_CD ,_, 10_CD %_NN FCS_NNP ,_, at_IN a_DT density_NN of_IN 1_CD ×_NN 10_CD
          6_CD cells_NNS /_NN ml_NN ,_, and_CC activated_VBN with_IN anti-_NN CD_NNP 3_CD (_( OKT_NNP 3_CD ,_, 1_CD :_: 500_CD ;_:
          Ortho_NNP Diagnostics_NNPS )_) ._. After_IN 72_CD hr_NN activation_NN ,_, PBMC_NNP were_VBD
          washed_VBN and_CC replaced_VBN in_IN culture_NN without_IN stimulation_NN for_IN
          36_CD -_: 40_CD hr_NN prior_RB to_TO restimulation_NN with_IN 1_CD nM_NN IL-_NNP 2_CD [_NN 16_CD ]_NN ._.
          To_TO purify_NN T_NN lymphocytes_NNS ,_, 72_CD hr_NN OKT_NNP 3_CD -_: activated_VBN PBMC_NNP were_VBD
          depleted_VBN of_IN CD_NNP 56_CD ,_, and_CC positively_RB selected_VBN for_IN CD_NNP 2_CD ,_, using_VBG
          antibody-conjugated_JJ magnetic_JJ beads_NNS (_( anti-_NN CD_NNP 56_CD
          Polysciences_NNP Inc_NNP ,_, anti-_NN CD_NNP 2_CD Dynal_NNP )_) according_VBG to_TO
          manufacturer_NN 's_POS instructions_NNS ._. Subsequent_JJ to_TO purification_NN ,_,
          T_NN cells_NNS were_VBD replaced_VBN in_IN culture_NN for_IN 36_CD -_: 40_CD hr_NN prior_RB to_TO
          restimulation_NN with_IN 1_CD nM_NN IL-_NNP 2_CD ,_, and_CC /_NN or_CC 10_CD μg_NN /_NN ml_NN
          cycloheximide_NN ._. Cell_NNP populations_NNS were_VBD stained_JJ with_IN
          anti-_NN CD_NNP 3_CD -_: APC_NNP ,_, CD_NNP 14_CD -_: FITC_NNP ,_, CD_NNP 19_CD -_: PerCP_NNP and_CC CD_NNP 56_CD -_: PE_NNP (_( Becton_NNP
          Dickinson_NNP )_) ,_, and_CC quantitated_JJ by_IN flow_NN cytometry_NN
          (_( FacsCalibur_NNP ,_, Becton_NNP Dickinson_NNP )_) ._.
        
        
          Microarray_NNP analysis_NN
          Five_CD independent_JJ experiments_NNS were_VBD performed_VBN with_IN PBMCs_NNP
          from_IN different_JJ donors_NNS ,_, and_CC four_CD independent_JJ experiments_NNS
          were_VBD carried_VBN out_IN with_IN purified_JJ T_NN cells_NNS ._. Protocols_NNP for_IN
          sample_NN preparation_NN and_CC array_NN hybridization_NN are_VBP from_IN
          Affymetrix_NNP ._. Briefly_NNP ,_, total_JJ cellular_JJ RNA_NNP was_VBD prepared_VBN with_IN
          Qiagen_NNP RNeasy_NNP reagents_NNS ,_, and_CC 5_CD μg_NN samples_NNS were_VBD used_VBN to_TO
          prepare_VB T_NN 7_CD -_: dT-primed_JJ double-stranded_JJ cDNA_NN (_( SuperScript_NNP
          Choice_NNP ,_, Invitrogen_NNP )_) ._. Biotin-labeled_NNP cRNA_NN was_VBD prepared_VBN by_IN
          in_IN vitro_NN transcription_NN (_( BioArray_NNP High-_NNP Yield_NNP T_NN 7_CD ,_, Enzo_NNP )_) ,_,
          and_CC hybridization_NN cocktails_NNS were_VBD prepared_VBN with_IN 20_CD μg_NN cRNA_NN
          per_IN sample_NN ._. Hybridization_NNP ,_, wash_VB ,_, and_CC staining_VBG of_IN
          Affymetrix_NNP human_JJ U_NNP 95_CD Av_NNP 2_CD arrays_NNS were_VBD performed_VBN following_VBG
          manufacturer_NN 's_POS instructions_NNS ._.
          Data_NNP analysis_NN was_VBD performed_VBN with_IN DNA-CHIP_NNP Analyzer_NNP
          software_NN [_NN 34_CD 58_CD ]_NN ._. Gene_NNP expression_NN values_NNS were_VBD
          normalized_JJ to_TO the_DT average_JJ chip_NN signal_NN intensity_NN for_IN each_DT
          experiment_NN ,_, and_CC a_DT 10_CD thpercentile_NN value_NN cut-off_JJ was_VBD used_VBN
          for_IN '_POS absent_JJ '_POS genes_NNS that_WDT did_VBD not_RB give_VB signals_NNS
          significantly_RB greater_JJR than_IN background_NN ._. To_TO calculate_VB
          IL-_NNP 2_CD -_: induced_VBN gene_NN expression_NN changes_NNS ,_, the_DT subtracted_VBN
          difference_NN values_NNS were_VBD determined_VBN by_IN subtracting_VBG the_DT
          signal_NN intensity_NN of_IN untreated_JJ samples_NNS from_IN the_DT values_NNS of_IN
          IL-_NNP 2_CD -_: treated_VBN samples_NNS ._. The_DT fold_VB difference_NN was_VBD calculated_VBN
          as_IN (_( IL-_NNP 2_CD -_: treated_VBN )_) /_NN (_( untreated_JJ )_) ._. Standard_JJ errors_NNS were_VBD
          derived_VBN from_IN 5_CD independent_JJ PBMC_NNP experiments_NNS ,_, and_CC 4_CD
          experiments_NNS with_IN purified_JJ T_NN cells_NNS ._. The_DT average_NN of_IN the_DT
          standard_JJ errors_NNS relative_JJ to_TO the_DT mean_JJ expression_NN values_NNS
          (_( SE_NNP /_NN mean_NN signal_NN intensity_NN )_) *_NN 100_CD %_NN was_VBD 22_CD %_NN for_IN untreated_JJ and_CC
          15_CD %_NN for_IN IL-_NNP 2_CD -_: stimulated_VBN PBMCs_NNP ,_, and_CC 16_CD %_NN and_CC 19_CD %_NN for_IN the_DT
          unstimulated_JJ and_CC IL-_NNP 2_CD -_: treated_VBN purified_JJ T_NN cell_NN samples_NNS ,_,
          respectively_RB ._. The_DT p-values_JJ were_VBD determined_VBN by_IN testing_VBG
          whether_IN the_DT absolute_JJ difference_NN between_IN treatment_NN group_NN
          means_VBZ is_VBZ not_RB zero_CD by_IN unpaired_JJ t-test_JJ ._.
        
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        The_DT results_NNS reported_VBD here_RB represent_VB almost_RB 20_CD years_NNS of_IN
        effort_NN ._. K_NNP ._. A_DT ._. S_NNP ._. initiated_VBD the_DT search_NN for_IN IL-_NNP 2_CD -_: regulated_VBN
        genes_NNS in_IN 1983_CD ,_, using_VBG subtractive_JJ hybridization_NN ,_, and_CC
        reported_VBD the_DT first_JJ IL-_NNP 2_CD -_: regulated_VBN gene_NN in_IN 1986_CD [_NN 16_CD ]_NN ._.
        C_NNP ._. B_NNP ._. extended_VBD these_DT initial_JJ efforts_NNS and_CC reported_VBD on_IN the_DT
        identification_NN of_IN 8_CD immediate_JJ /_NN early_JJ IL-_NNP 2_CD -_: induced_VBN genes_NNS in_IN
        1993_CD [_NN 33_CD ]_NN ._. C_NNP ._. B_NNP ._. conceived_VBD and_CC performed_VBD the_DT experiments_NNS
        contained_VBD in_IN this_DT report_NN ,_, and_CC wrote_VBD the_DT manuscript_NN ._. K_NNP ._. A_DT ._. S_NNP ._.
        provided_VBN advice_NN in_IN experimental_JJ design_NN and_CC analysis_NN of_IN the_DT
        results_NNS ,_, and_CC contributed_VBD to_TO the_DT revisions_NNS of_IN the_DT manuscript_NN
        that_IN eventually_RB resulted_VBD in_IN the_DT final_JJ version_NN ._.
      
    
  
